Literature DB >> 2898233

Pharmacology of dynorphin.

A P Smith1, N M Lee.   

Abstract

Like other opioids, the dynorphins play a role in wide variety of physiological parameters, including pain regulation, motor activity, cardiovascular regulation, respiration, temperature regulation, feeding behavior, hormone balance, and the response to shock or stress. The dynorphins are unusual if not unique, however, in that they frequently modulate the activity of other opioids, rather than having direct effects themselves. Thus, they are not analgesic in brain, yet they antagonize opioid analgesia in naive animals and potentiate it in tolerant animals. They have little or no effect by themselves on temperature regulation or respiration, but they enhance the acute effects of morphine on these parameters. Their beneficial effects on stroke are like those of opioid antagonists rather than like agonists. Consistent with such a wide variety of physiological effects, the dynorphins bind to all three of the major opioid receptor types in brain, mu, delta, and kappa, though they exhibit some preference toward kappa sites. They also seem to interact with other physiologically relevant sites; though on the basis of their sensitivity to des-Tyr fragments of dynorphine and/or their insensitivity to naloxone, these sites have been termed "non-opioid". No second messenger systems have been directly associated with dynorphine binding, but several likely candidates exist.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898233     DOI: 10.1146/annurev.pa.28.040188.001011

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  12 in total

1.  Effect of dynorphin A(1-13) on cardiomyocytes in culture: modulation of the response to increased extracellular calcium, but no effect on intrinsic cardiac contractile frequency or the response to isoproterenol or increased extracellular potassium.

Authors:  S W Rabkin
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

Review 2.  Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

Authors:  V K Shukla; S Lemaire
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

3.  Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference.

Authors:  Jeffrey S Smith; Abigail G Schindler; Emma Martinelli; Richard M Gustin; Michael R Bruchas; Charles Chavkin
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

Review 4.  Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats.

Authors:  Jana Bundzikova; Zdeno Pirnik; Dora Zelena; Jens D Mikkelsen; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.046

5.  Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.

Authors:  M Hiramatsu; K Inoue; A Ambo; Y Sasaki; T Kameyama
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  A direct chemical interaction between dynorphin and excitatory amino acids.

Authors:  A Woods; A Zangen
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

7.  Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period.

Authors:  Alberto Loizzo; Stefano Loizzo; Luisa Lopez; Antonio d'Amore; Paolo Renzi; Santi Spampinato; Simonetta Di Carlo; Antonella Bacosi; Piergiorgio Zuccaro; Roberta Pacifici
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

8.  Separation of dynorphin peptides by capillary electrochromatography using a polydiallyldimethylammonium chloride gold nanoparticle-modified capillary.

Authors:  Abdullah M Al-Hossaini; Leena Suntornsuk; Susan M Lunte
Journal:  Electrophoresis       Date:  2016-06-16       Impact factor: 3.535

9.  Changes in prodynorphin gene expression and neuronal morphology in the hypothalamus of postmenopausal women.

Authors:  A M Rometo; N E Rance
Journal:  J Neuroendocrinol       Date:  2008-12       Impact factor: 3.627

Review 10.  Peptide kappa opioid receptor ligands: potential for drug development.

Authors:  Jane V Aldrich; Jay P McLaughlin
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.